About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Lpl
lipoprotein lipase
MGI:96820
38 phenotypes from 3 alleles in 5 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Lpltm1Bres/Lpl+
involves: 129S4/SvJae
increased body weight J:134171
increased cholesterol level J:134171
increased total fat pad weight J:134171
increased triglyceride level J:134171
Lpltm1Bres/Lpl+
involves: 129S4/SvJae * C57BL/6J
abnormal lipid homeostasis J:30062
increased circulating cholesterol level J:30062
increased circulating triglyceride level J:30062
increased circulating VLDL cholesterol level J:30062
increased circulating VLDL triglyceride level J:30062
Lpltm1Bres/Lpltm1Bres
involves: 129S4/SvJae * C57BL/6J
abnormal adipose tissue morphology J:30062
abnormal capillary morphology J:30062
abnormal lipid homeostasis J:30062
abnormal liver morphology J:30062
abnormal lung vasculature morphology J:30062
abnormal pulmonary alveolus morphology J:30062
abnormal skeletal muscle morphology J:30062
cyanosis J:30062
decreased circulating HDL cholesterol level J:30062
decreased circulating LDL cholesterol level J:30062
increased circulating cholesterol level J:30062
increased circulating triglyceride level J:30062
increased circulating VLDL cholesterol level J:30062
neonatal lethality, complete penetrance J:30062
pallor J:30062
Lpltm1Ijg/Lpltm1Ijg
Tg(Myh6-cre)2182Mds/?
involves: C57BL/6
abnormal glucose homeostasis J:90737
abnormal lipid level J:90737
decreased cardiac muscle triglyceride level J:90737
decreased fatty acids level J:90737
increased cardiac muscle cell glucose uptake J:90737
increased circulating triglyceride level J:90737
increased circulating VLDL triglyceride level J:90737
Lpltm1Ijg/Lpltm1Ijg
Tg(Myh6-cre)2182Mds/0
involves: FVB/N
abnormal cardiovascular system physiology J:110484
abnormal glucose homeostasis J:110484
cardiac fibrosis J:110484
cardiac interstitial fibrosis J:110484
decreased heart left ventricle muscle contractility J:110484
increased cardiac muscle cell glucose uptake J:110484
increased circulating triglyceride level J:110484
increased left ventricle diastolic pressure J:110484
increased left ventricle systolic pressure J:110484
increased susceptibility to induced morbidity/mortality J:110484
Lpltm1Sem/Lpl+
involves: 129P2/OlaHsd * C57BL/6J
abnormal lipid homeostasis J:25652
increased circulating cholesterol level J:25652
increased circulating HDL cholesterol level J:25652
increased circulating phospholipid level J:25652
increased circulating triglyceride level J:25652
increased circulating VLDL triglyceride level J:25652
Lpltm1Sem/Lpltm1Sem
involves: 129P2/OlaHsd * C57BL/6J
atelectasis J:25652
decreased circulating HDL cholesterol level J:25652
hyperlipidemia J:25652
increased circulating cholesterol level J:25652
increased circulating phospholipid level J:25652
increased circulating triglyceride level J:25652
liver vascular congestion J:25652
neonatal lethality, complete penetrance J:25652
pulmonary vascular congestion J:25652

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory